Tag: Aspen Neuroscience

Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs

Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs

SAN DIEGO, Nov. 20, 2025 /PRNewswire/ — Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced the closing of a $115 million Series C financing round. This significant investment will fuel the continued clinical…

Read More Read More

Aspen Neuroscience has filed a notice of an exempt offering of securities to raise $40,000,000.00 in New Debt Financing.

Aspen Neuroscience has filed a notice of an exempt offering of securities to raise $40,000,000.00 in New Debt Financing.

According to filings with the U.S. Securities and Exchange Commission, Aspen Neuroscience is raising $40,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Howard Federoff played a key role in…

Read More Read More